Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402].

Iro, M; Snape, M; Voysey, M; Jawad, S; Finn, A; Heath, P; Bona, G; Esposito, S; Diez-Domingo, J; Prymula, R; Odueyungbo, A; Toneatto, D; Dull, P; Pollard, A; European Men B Vaccine Study Group

Journal article

Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402].

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Iro, M., Snape, M., Voysey, M., Jawad, S., Finn, A., Heath, P., Bona, G., Esposito, S., Diez-Domingo, J., Prymula, R., Odueyungbo, A., Toneatto, D., Dull, P., Pollard, A., & Group, E. M. B. V. S. (2017). Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]. Vaccine, 35(24), 2379.

MLA Style

Iro, M, et al. “Corrigendum to ‘Persistence of Bactericidal Antibodies Following Booster Vaccination with 4CMenB at 12, 18 or 24months and Immunogenicity of a Fifth Dose Administered at 4years of Age-a Phase 3 Extension to a Randomised Controlled Trial’ [Vaccine 35 (2017) 395-402].” Vaccine, vol. 35, no. 24, 2017, p. 2379.

Chicago Style

Iro, M, M Snape, M Voysey, et al. 2017. “Corrigendum to ‘Persistence of Bactericidal Antibodies Following Booster Vaccination with 4CMenB at 12, 18 or 24months and Immunogenicity of a Fifth Dose Administered at 4years of Age-a Phase 3 Extension to a Randomised Controlled Trial’ [Vaccine 35 (2017) 395-402].” Vaccine 35 (24): 2379.
Print